Attributable causes of cancer in Japan in 2005-Systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan

Annals of Oncology

Volumn 23, Issue 5, 2012, Pages 1362-1369

  Inoue, M ^a   Sawada, N ^a   Matsuda, T ^a   Iwasaki, M ^a   Sasazuki, S ^a   Shimazu, T ^a   Shibuya, K ^b   Tsugane, S ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer; Japan; Population attributable fraction; Risk factor

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CAUSAL ATTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; FEMALE; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; INFECTION; JAPAN; MALE; MALIGNANT NEOPLASTIC DISEASE; OBESITY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; RISK REDUCTION; SALT INTAKE; SEX DIFFERENCE; SMOKING HABIT;

EID: 84860470962     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr437     Document Type: Article

References (42)

1. Ministry of Health, Labour and Welfare. Vital Statistics of Japan, 1958-2009. Tokyo, Japan: Ministry of Health, Labour and Welfare.
2. The Editorial Board of the Cancer Statistics in Japan. Cancer Statistics in Japan 2010. Tokyo, Japan: Foundation for Promotion of Cancer Research 2010.
3. Matsuda T, Marugame T, Kamo KI et al. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2011; 41: 139-147.
4. International Agency for Research on Cancer. World Cancer Report 2008. Lyon, France: WHO Press 2008.
5. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191-1308.
6. Harvard Report on Cancer Prevention. Volume 1: Causes of human cancer. Cancer Causes Control 1996; 7 (Suppl 1): S3-S59.
7. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411: 390-395.
8. Olsen JH. Avoidable cancers in the Nordic countries. Aims and background. APMIS Suppl 1997; 76: 1-8.
9. Olsen JH, Andersen A, Dreyer L et al. Summary of avoidable cancers in the Nordic countries. APMIS Suppl 1997; 76: 141-146.
10. Boffetta P, Tubiana M, Hill C et al. The causes of cancer in France. Ann Oncol 2009; 20: 550-555.
11. International Agency for Research on Cancer. Attributable Causes of Cancer in France in the Year 2000. IARC Working Group Report, Vol. 3. Lyon, France: IARC Scientific Publications, 2007.
12. Danaei G, Vander Hoorn S, Lopez AD et al. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; 366: 1784-1793.
13. Wang JB, Jiang Y, Wei WQ et al. Estimation of cancer incidence and mortality attributable to smoking in China. Cancer Causes Control 2010; 21: 959-965.
14. Liang H, Wang J, Xiao H et al. Estimation of cancer incidence and mortality attributable to alcohol drinking in China. BMC Public Health 2010; 10: 730.
15. Xiang W, Shi JF, Li P et al. Estimation of cancer cases and deaths attributable to infection in China. Cancer Causes Control 2011; 22: 1153-1161.
16. Shin A, Park S, Shin HR et al. Population attributable fraction of infection-related cancers in Korea. Ann Oncol 2011; 22: 1435-1442.
17. Murray CJ, Lopez AD. On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology 1999; 10: 594-605.
18. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 1-100, 1987-2011. Lyon, France.
19. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR 2007.
20. International Agency for Research on Cancer. IARC Handbooks for Cancer Prevention, Vol. 1-13. Lyon, France.
21. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-427.
22. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953; 9: 531-541.
23. Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health 2001; 55: 508-514.
24. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974; 99: 325-332.
25. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044.
26. Ezzati M, Hoorn SV, Rodgers A et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003; 362: 271-280.
27. Sobue T, Yamamoto S, Hara M et al. Cigarette smoking and subsequent risk of lung cancer by histologic type in middle-aged Japanese men and women: the JPHC study. Int J Cancer 2002; 99: 245-251.
28. Zheng W, McLerran DF, Rolland B et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 2011; 364: 719-729.
29. Gandini S, Botteri E, Iodice S et al. Tobacco smoking and cancer: a metaanalysis. Int J Cancer 2008; 122: 155-164.
30. US EPA. Respiratory Health Effect of Passive Smoking: Lung Cancer and Other Disorders. Washington, DC: Agency UEP 1992.
31. Zhong L, Goldberg MS, Gao YT, Jin F. Lung cancer and indoor air pollution arising from Chinese-style cooking among nonsmoking women living in Shanghai, China. Epidemiology 1999; 10: 488-494.
32. Curado M, Edwards B, Shin HR et al. Cancer Incidence in Five Continents, Vol. IX. In IARC Scientific Publications No. 160, Lyon, France: IARC Scientific Publications,2007.
33. Asaka M, Kimura T, Kudo M et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760-766.
34. Replogle ML, Kasumi W, Ishikawa KB et al. Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan. Int J Epidemiol 1996; 25: 210-214.
35. Tanaka H, Uera F, Tsukuma H et al. Distinctive change in male liver cancer incidence rate between the 1970s and 1990s in Japan: comparison with Japanese-Americans and US whites. Jpn J Clin Oncol 2007; 37: 193-196.
36. Arisawa K, Soda M, Endo S et al. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 2000; 85: 319-324.
37. Mizoue T, Inoue M, Wakai K et al. Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am J Epidemiol 2008; 167: 1397-1406.
38. Ministry of Health, Labour and Welfare. National Nutrition Survey (National Health and Nutrition Survey since 2003) Japan, 1975-2008. Tokyo, Japan.
39. Parr CL, Batty GD, Lam TH et al. Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. Lancet Oncol 2010; 11: 741-752.
40. Takachi R, Inoue M, Shimazu T et al. Consumption of sodium and salted foods in relation to cancer and cardiovascular disease: the Japan Public Health Centerbased Prospective Study. Am J Clin Nutr 2010; 91: 456-464.
41. Boffetta P, Autier P, Boniol M et al. An estimate of cancers attributable to occupational exposures in France. J Occup Environ Med 2010; 52: 399-406.
42. Ott JJ, Ullrich A, Mascarenhas M, Stevens GA. Global cancer incidence and mortality caused by behavior and infection. J Public Health (Oxf) 2011; 33: 223-233.